News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
722,263 Results
Type
Article (45260)
Company Profile (353)
Press Release (676650)
Section
Business (214224)
Career Advice (2272)
Deals (37363)
Drug Delivery (109)
Drug Development (84481)
Employer Resources (175)
FDA (16760)
Job Trends (15622)
News (362820)
Policy (34887)
Tag
Academia (2653)
Alliances (52258)
Alzheimer's disease (1290)
Approvals (16680)
Artificial intelligence (162)
Bankruptcy (371)
Best Places to Work (11816)
Biotechnology (226)
Breast cancer (171)
Cancer (1337)
Cardiovascular disease (115)
Career advice (1895)
Cell therapy (284)
Clinical research (67337)
Collaboration (467)
Compensation (251)
COVID-19 (2684)
C-suite (112)
Data (1355)
Diabetes (172)
Diagnostics (6333)
Earnings (87945)
Employer resources (154)
Events (114989)
Executive appointments (370)
FDA (17395)
Funding (417)
Gene therapy (208)
GLP-1 (667)
Government (4621)
Healthcare (19205)
Infectious disease (2778)
Inflammatory bowel disease (116)
Interviews (356)
IPO (16864)
Job creations (4203)
Job search strategy (1626)
Layoffs (457)
Legal (8626)
Lung cancer (193)
Manufacturing (214)
Medical device (13457)
Medtech (13462)
Mergers & acquisitions (20607)
Metabolic disorders (481)
Neuroscience (1621)
NextGen Class of 2024 (6765)
Non-profit (4583)
Northern California (1640)
Obesity (281)
Opinion (225)
Patents (121)
People (59438)
Pharmaceutical (107)
Phase I (20947)
Phase II (29554)
Phase III (22193)
Pipeline (505)
Postmarket research (2723)
Preclinical (8877)
Radiopharmaceuticals (249)
Rare diseases (262)
Real estate (6458)
Regulatory (23084)
Research institute (2414)
Resumes & cover letters (380)
Southern California (1428)
Startups (3814)
United States (14945)
Vaccines (601)
Weight loss (218)
Date
Today (152)
Last 7 days (667)
Last 30 days (3008)
Last 365 days (36539)
2024 (35334)
2023 (41160)
2022 (52386)
2021 (56924)
2020 (55455)
2019 (48185)
2018 (36452)
2017 (33933)
2016 (33632)
2015 (39468)
2014 (33429)
2013 (28591)
2012 (30666)
2011 (31335)
2010 (29332)
Location
Africa (825)
Arizona (205)
Asia (43088)
Australia (6670)
California (3701)
Canada (1398)
China (303)
Colorado (170)
Connecticut (174)
Europe (89431)
Florida (515)
Georgia (129)
Illinois (383)
Indiana (227)
Maryland (627)
Massachusetts (2921)
Michigan (168)
Minnesota (286)
New Jersey (1078)
New York (1051)
North Carolina (785)
Northern California (1640)
Ohio (149)
Pennsylvania (899)
South America (1207)
Southern California (1428)
Texas (534)
Utah (108)
Washington State (393)
722,263 Results for "china pharma holdings inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split
China Pharma Holdings Inc. reported that it expects to implement a 1-for-5 reverse stock split on its common stock effective Wednesday, March 6, 2024, with trading to begin on a split-adjusted basis at the market open on that day.
February 23, 2024
·
3 min read
ADCs
GSK Turns Back to China in Another Potential $1B+ ADC Deal
One year after a potential $1.7 billion deal with Hansoh Pharma, GSK goes back to China to forge another alliance with DualityBio for another deal that could be worth up to $1 billion as it continues to build up its ADC portfolio.
December 4, 2024
·
1 min read
·
Kate Goodwin
China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device
China Pharma Holdings, Inc. announced that its Dry Eye Disease therapeutic device has passed third-party testing and is preparing to apply for market launch to the National Medical Products Administration of China.
November 29, 2023
·
3 min read
China
AstraZeneca Names New International Operations Lead Amid Probe on China Exec
Iskra Reic will continue to serve as the pharma’s senior vice president for Vaccines and Immune Therapies as she steps in for Leon Wang, who was detained by Chinese authorities in November.
December 5, 2024
·
3 min read
·
Tristan Manalac
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Press Releases
LEO Pharma Submits New Drug Application for Enstilar® for Adults with Plaque Psoriasis in China
September 27, 2024
·
6 min read
Press Releases
Atom Therapeutics and China Medical System Holdings Enter Exclusive Commercialization Agreement for Lingdolinurad (ABP-671) to Treat Chronic Gout and Hyperuricemia
December 3, 2024
·
4 min read
Business
The Biggest Pharma Share Moves of the Year So Far
Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share price. Other companies have not been so lucky.
November 27, 2024
·
9 min read
·
Annalee Armstrong
Podcast
AbbVie’s Surprise Schizophrenia Flop, AstraZeneca’s China Drama, Hope in Huntington’s, More
A tale of two multi-billion schizophrenia deals, AstraZeneca touts strong sales while deflecting questions about an investigation into China exec, the Huntington’s pipeline builds momentum and layoffs continue with Sana Biotechnology and 23andMe.
November 13, 2024
·
1 min read
·
Heather McKenzie
Press Releases
Zai Lab Announces the Inclusion of AUGTYRO® (repotrectinib) for ROS1+ NSCLC and Other Updates in China’s National Reimbursement Drug List
November 28, 2024
·
8 min read
1 of 72,227
Next
